These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7054385

  • 1. Dependency of tricyclic antidepressant efficacy on thyroid hormone potentiation: case studies.
    Swartz CM.
    J Nerv Ment Dis; 1982 Jan; 170(1):50-2. PubMed ID: 7054385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Triiodothyronine potentiation of the antidepressant effect of phenelzine.
    Joffe RT.
    J Clin Psychiatry; 1988 Oct; 49(10):409-10. PubMed ID: 3170493
    [Abstract] [Full Text] [Related]

  • 5. Failure of T3 to potentiate tricyclic antidepressant response.
    Gitlin MJ, Weiner H, Fairbanks L, Hershman JM, Friedfeld N.
    J Affect Disord; 1987 Oct; 13(3):267-72. PubMed ID: 2960719
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Triiodothyronine potentiation of fluoxetine in depressed patients.
    Joffe RT.
    Can J Psychiatry; 1992 Feb; 37(1):48-50. PubMed ID: 1551045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression.
    Rogóz Z, Skuza G, Daniel WA, Wójcikowski J, Dudek D, Wróbel A.
    Pharmacol Rep; 2007 Feb; 59(6):778-84. PubMed ID: 18195470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression.
    Joffe RT, Singer W, Levitt AJ, MacDonald C.
    Arch Gen Psychiatry; 1993 May; 50(5):387-93. PubMed ID: 8489327
    [Abstract] [Full Text] [Related]

  • 14. Use of a thyroid hormone to accelerate the action of imipramine.
    Prange AJ, Wilson IC, Lipton MA, Rabon AM, McClae TK, Knox AE.
    Psychosomatics; 1970 May; 11(5):442-4. PubMed ID: 5470670
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC, Mayo JP, Gillette GM, Little KY, Mason GA.
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [Abstract] [Full Text] [Related]

  • 17. T3 augmentation of antidepressant treatment in T4-replaced thyroid patients.
    Cooke RG, Joffe RT, Levitt AJ.
    J Clin Psychiatry; 1992 Jan; 53(1):16-8. PubMed ID: 1737734
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical usefulness of monitoring serum levels of imipramine and desipramine in patients treated for endogenous depression].
    Szymura-Oleksiak J, Wasieczko A.
    Psychiatr Pol; 1991 Jan; 25(1):54-60. PubMed ID: 1780375
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.